Results 241 to 250 of about 1,937,987 (265)

Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia

, 2010
Daniel W. Bougie, Dhirendra Nayak, Brian Boylan, Peter J. Newman, Richard H. Aster   +4 more
openalex   +2 more sources

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK. [PDF]

J Mark Access Health Policy
Cooper N, Guterres S, Pochopień M, Wilson K, James S, Toumi M, Tytuła A, Rich C, Eriksson D.   +8 more
europepmc   +1 more source

Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study. [PDF]

J Clin Med
Zoletto S, Pizzi M, De Crescenzo A, Friziero A, D'Amore F, Carli G, Vianelli N, Auteri G, Bertozzi I, Nichele I, Binotto G, Dei Tos AP, Scarmozzino F, D'Amore ESG, Ceccato J, Sabattini E, Cinetto F, Piazza F, Visentin A, Zambello R, Trentin L, Vianello F.   +21 more
europepmc   +1 more source

Prognostic factors and long-term outcome in dogs diagnosed with primary and secondary immune thrombocytopenia in Ireland. [PDF]

J Small Anim Pract
López-Bailén E, Duclos A, Mullany D, Le Boedec K, Cuq B.   +4 more
europepmc   +1 more source

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia

, 2011
Andrew R. Crow, Sara J. Suppa, Xi Chen, Patrick J. Mott, Alan H. Lazarus   +4 more
openalex   +1 more source

Hetrombopag treatment for immune thrombocytopenia in pregnancy refractory to corticosteroids and intravenous immunoglobulin: a case report. [PDF]

Front Med (Lausanne)
Pang L, Yu F, Yang X.
europepmc   +1 more source

Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment. [PDF]

Curr Issues Mol Biol
Zheng SS, Perdomo JS.
europepmc   +1 more source

Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia. [PDF]

Int J Hematol
Kuwana M, Tomiyama Y.
europepmc   +1 more source

Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia - Case Report. [PDF]

Immunotargets Ther
Zoubi I, Warwar A, Perek S, Preis M.
europepmc   +1 more source

Impact of platelet transfusion and bleeding risk stratification in patients with immune thrombocytopenia before procedures. [PDF]

Sci Rep
Kang KW, Choi Y, Lim HJ, Kwak K, Choi YS, Park Y, Kim BS, Lee KS, Ahn KH.   +8 more
europepmc   +1 more source